U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C11H19O2.Zn
Molecular Weight 431.944
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZINC UNDECYLENATE

SMILES

[Zn++].[O-]C(=O)CCCCCCCCC=C.[O-]C(=O)CCCCCCCCC=C

InChI

InChIKey=YMCOHQVWOBMDCZ-UHFFFAOYSA-L
InChI=1S/2C11H20O2.Zn/c2*1-2-3-4-5-6-7-8-9-10-11(12)13;/h2*2H,1,3-10H2,(H,12,13);/q;;+2/p-2

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including http://www.altmedrev.com/publications/7/1/68.pdf | https://www.ncbi.nlm.nih.gov/pubmed/10991877

Undecylenic acid is unsaturated fatty acid, which naturally occurs in sweat, and is commercially produced by the vacuum distillation of castor bean oil. It is recognized as GRASE by FDA, and is marketed over the counter to treat skin infections and to relieve itching. Undecylenic acid acts by inhibition of morphogenesis from yeast to hyphae forms.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
CRUEX

Approved Use

For the cure of most tinea pedis (athlete's foot) and tinea corporis (ringworm).
Curative
CRUEX

Approved Use

For the cure of most tinea pedis (athlete's foot) and tinea corporis (ringworm).
Primary
Unknown

Approved Use

Unknown
Primary
CRUEX

Approved Use

Itching, burning, redness, irritation, scaling, soreness and discomfort which may accompany these conditions
Doses

Doses

DosePopulationAdverse events​
2.2 g 3 times / day multiple, oral
Dose: 2.2 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.2 g, 3 times / day
Co-administed with::
nicotinic acid(50 mgm. morning and night)
Sources:
unhealthy, 56 years
n = 1
Health Status: unhealthy
Condition: psoriasis
Age Group: 56 years
Sex: M
Population Size: 1
Sources:
Disc. AE: Toxic labyrinthitis...
AEs leading to
discontinuation/dose reduction:
Toxic labyrinthitis (1 patient)
Sources:
1 g 3 times / day multiple, oral
Dose: 1 g, 3 times / day
Route: oral
Route: multiple
Dose: 1 g, 3 times / day
Sources:
unhealthy, 8-14 years
n = 4
Health Status: unhealthy
Condition: psoriasis | NEURODERMATITIS
Age Group: 8-14 years
Population Size: 4
Sources:
10 g 3 times / day multiple, oral
Highest studied dose
Dose: 10 g, 3 times / day
Route: oral
Route: multiple
Dose: 10 g, 3 times / day
Sources:
unhealthy, adult
Health Status: unhealthy
Condition: psoriasis
Age Group: adult
Sources:
2 % 1 times / day multiple, topical
Dose: 2 %, 1 times / day
Route: topical
Route: multiple
Dose: 2 %, 1 times / day
Co-administed with::
zinc undecylenate(0.2)
Sources:
unhealthy
n = 29
Health Status: unhealthy
Condition: TINEA PEDIS
Population Size: 29
Sources:
AEs

AEs

AESignificanceDosePopulation
Toxic labyrinthitis 1 patient
Disc. AE
2.2 g 3 times / day multiple, oral
Dose: 2.2 g, 3 times / day
Route: oral
Route: multiple
Dose: 2.2 g, 3 times / day
Co-administed with::
nicotinic acid(50 mgm. morning and night)
Sources:
unhealthy, 56 years
n = 1
Health Status: unhealthy
Condition: psoriasis
Age Group: 56 years
Sex: M
Population Size: 1
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Screening for new compounds with antiherpes activity.
1984 Oct
Application of linear solvation energy relationships to polymeric pseudostationary phases in micellar electrokinetic chromatography.
2001 Apr
Convenient formation of 4-hydroxyalk-2-en-1-one functionality via A knoevenagel-type carbon chain elongation reaction of aldehyde with 1-arylsulfinylalkan-2-one.
2001 Feb 23
Allergic contact dermatitis from undecylenic acid in a commercial antifungal nail solution.
2002 Feb
Determination of undecylenic and sorbic acids in cosmetic preparations by high performance liquid chromatography with electrochemical detection.
2002 Nov 7
Surface functionalization of silicon nanoparticles produced by laser-driven pyrolysis of silane followed by HF-HNO3 etching.
2004 May 25
Kinetic control of the photochemical reactivity of hydrogen-terminated silicon with bifunctional molecules.
2005 May 24
Silicon nanoparticles: applications in cell biology and medicine.
2006
Self-assembled thermo- and pH responsive micelles of poly(10-undecenoic acid-b-N-isopropylacrylamide) for drug delivery.
2006 Dec 1
Well-defined carboxyl-terminated alkyl monolayers grafted onto H-Si(111): packing density from a combined AFM and quantitative IR study.
2006 Jan 3
Simple fluorimetric liquid chromatographic method for the analysis of undecylenic acid and zinc undecylenate in pharmaceutical preparations.
2006 Jun 30
UV photodissociation spectroscopy of oxidized undecylenic acid films.
2006 Mar 16
Tailor-made olefinic medium-chain-length poly[(R)-3-hydroxyalkanoates] by Pseudomonas putida GPo1: batch versus chemostat production.
2006 Mar 5
Grazing angle mirror-backed reflection (GMBR) for infrared analysis of monolayers on silicon.
2006 Sep 14
Mechanisms of thermal decomposition of organic monolayers grafted on (111) silicon.
2007 Jan 30
Structure and polymer form of poly-3-hydroxyalkanoates produced by Pseudomonas oleovorans grown with mixture of sodium octanoate/undecylenic acid and sodium octanoate/5-phenylvaleric acid.
2007 Jan 30
Self-assembled monolayers with latent aldehydes for protein immobilization.
2007 Jan-Feb
Covalent biofunctionalization of silicon nitride surfaces.
2007 May 22
Cell adhesion properties on photochemically functionalized diamond.
2007 May 8
Determination of nateglinide in human plasma by high-performance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent.
2007 Sep 5
A new concept in the topical treatment of onychomycosis with cyanoacrylate, undecylenic acid, and hydroquinone.
2008 Apr
Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
2008 Jun
Porous silicon for photosensitized formation of singlet oxygen in water and in simulated body fluid: two methods of modification by undecylenic acid.
2009 Jun
Electrochemical behavior of gold colloidal alkyl modified silicon surfaces.
2009 Nov
Stimulatory effect of undecylenic acid on mouse osteoblast differentiation.
2010 Apr
Simple surface modification of poly(dimethylsiloxane) for DNA hybridization.
2010 Dec 6
Rapid approach to biobased telechelics through two one-pot thiol-ene click reactions.
2010 Jun 14
Production of functionalized polyhydroxyalkanoates by genetically modified Methylobacterium extorquens strains.
2010 Sep 16
Patents

Sample Use Guides

Undecylenic acid antifungal liquid should be applied to affected area topically.
Route of Administration: Topical
To investigate effect of undecylenic acid on Candida albicans morphogenesis, cells were grown overnight at 30°C on YPD agar and harvested by scraping the cells from the plate and suspending in YPD broth. Two milliliters of cells at 106 cells/ml was distributed into tubes containing liner, approximately 0.5 g of liner per tube. The cultures were incubated at 39°C with agitation for 2 h; planktonic cells were analyzed microscopically to determine the percentage of cells with germ tubes. The presence of Undecylenic acid inhibited the appearance of germ tubes, with 10 μM UDA causing a sevenfold reduction.
Name Type Language
ZINC UNDECYLENATE
EP   INCI   JAN   USP   VANDF   WHO-DD  
INCI  
Official Name English
ZINC UNDECYLENATE [JAN]
Common Name English
UNDECYLENIC ACID ZINC SALT
MI  
Common Name English
ZINC UNDECYLENATE [VANDF]
Common Name English
ZINC UNDECENOATE [MART.]
Common Name English
NSC-402438
Code English
ZINC UNDECYLENATE [INCI]
Common Name English
ZINC UNDECENOATE
MART.  
Systematic Name English
Zinc undecylenate [WHO-DD]
Common Name English
ZINC UNDECYLENATE [USP MONOGRAPH]
Common Name English
10-UNDECENOIC ACID, ZINC (2+) SALT
Common Name English
UNDECYLENIC ACID ZINC SALT [MI]
Common Name English
ZINC UNDECYLENATE [EP MONOGRAPH]
Common Name English
UNDECYLENATE ZINC
VANDF  
Common Name English
Zinc 10-undecenoate
Systematic Name English
UNDECYLENATE ZINC [VANDF]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C514
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
CFR 21 CFR 333.210
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
Code System Code Type Description
SMS_ID
100000089534
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
EVMPD
SUB15763MIG
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
NSC
402438
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
ECHA (EC/EINECS)
209-155-0
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
NCI_THESAURUS
C29552
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
RXCUI
89748
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY RxNorm
PUBCHEM
11179
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
FDA UNII
388VZ25DUR
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
DRUG BANK
DBSALT001529
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
MERCK INDEX
m11303
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY Merck Index
DAILYMED
388VZ25DUR
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
RS_ITEM_NUM
1724780
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
CAS
557-08-4
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
EPA CompTox
DTXSID90890497
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY
DRUG CENTRAL
4457
Created by admin on Fri Dec 15 15:01:08 GMT 2023 , Edited by admin on Fri Dec 15 15:01:08 GMT 2023
PRIMARY